 LAVAL, QC and CAMBRIDGE, England, Nov. 5, 2020 PRNewswire - Liminal BioSciences Inc. NASDAQ: LMNL Liminal BioSciences or the Company, a clinical-stage biopharmaceutical company, today announced the acceptance of two abstracts related to the Companys clinical development... 